Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes

NCT04859218 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT04859218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04859218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes
Lead sponsor
McMaster University
Phase
Not applicable
Overall status
Completed
Start date
October 17, 2023
Completion date
September 10, 2026
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome